Clinical Trial Update: Bosentan Use in Patients With Diabetic Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial investigating bosentan in patients with diabetic nephropathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bosentan (Bosentan)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Type 2 Diabetes | Phase 3 | Status: TERMINATED